Patent Armory v. HealthMarkets: Voluntary Dismissal in Call Routing Patent Dispute in 94 Days
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Patent Armory, Inc. v. HealthMarkets, Inc. |
| Case Number | 2:24-cv-00028 (E.D. Tex.) |
| Court | Eastern District of Texas, under Chief Judge Rodney Gilstrap |
| Duration | January 19, 2024 – April 22, 2024 94 days |
| Outcome | Plaintiff Voluntary Dismissal — No Damages |
| Patents at Issue | |
| Accused Products | HealthMarkets’ intelligent communication routing infrastructure and consumer-matching systems |
Case Overview
The Parties
⚖️ Plaintiff
Patent assertion entity (PAE) with a focused portfolio in telecommunications routing and intelligent call-handling technologies.
🛡️ Defendant
Health insurance distribution company operating technology platforms that connect consumers with insurance products.
The Patents at Issue
This case centered on five patents covering intelligent communication routing, telephony control systems, and auction-based entity matching technology, critical for automated customer service and lead generation platforms.
- • US9456086B1 — Intelligent communication routing system and method
- • US10491748B1 — Method and system for matching entities in an auction
- • US7269253B1 — Telephony control system with intelligent call routing
- • US7023979B1 — Telephony control system with intelligent call routing
- • US10237420B1 — Intelligent communication routing system and method
Developing a call routing or matching system?
Check if your technology might infringe these or related patents before deployment.
The Verdict & Legal Analysis
Outcome
The case was **dismissed without prejudice** pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(i). No damages were awarded, no injunctive relief was granted, and each party was ordered to bear its own costs, expenses, and attorneys’ fees. All pending relief requests were denied as moot.
Key Legal Issues
The rapid voluntary dismissal of this case before significant motion practice highlights several strategic and legal dimensions:
The “Without Prejudice” Variable: This outcome leaves Patent Armory free to reassert the same five patents against HealthMarkets at a future date, preserving maximum plaintiff flexibility.
Lead Case Continuity: The explicit judicial instruction to maintain Lead Case No. 2:24-cv-00030 against additional defendants signals a coordinated, multi-defendant assertion campaign, where this dismissal likely reflects a defendant-specific resolution.
No Prosecution History Estoppel Created: Because no claim construction or infringement analysis was entered, Patent Armory’s future assertion options remain unconstrained by judicial interpretation of claim language, a significant litigation asset for the patent holder.
Freedom to Operate (FTO) Analysis & Implications
This case highlights critical IP risks in telecommunications routing and insurtech. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation.
- View all related patents in intelligent call routing
- See which companies are most active in telecom patents
- Understand claim construction patterns for routing systems
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own communication routing technology.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Intelligent call routing & entity matching
5 Active Patents
In intelligent routing space
Design-Around Options
Available, but requires careful analysis
✅ Key Takeaways for IP Strategy
Rule 41(a)(1)(A)(i) dismissals in multi-defendant NPE campaigns often reflect per-defendant licensing resolution, not portfolio retreat.
Search related case law →No adverse claim construction or validity findings were created — these patents remain judicially uninterpreted.
Explore precedents →Frequently Asked Questions
Five U.S. patents: US9456086B1, US10491748B1, US7269253B1, US7023979B1, and US10237420B1, covering intelligent call routing and auction-based entity matching technologies.
Plaintiff Patent Armory filed a voluntary dismissal under Rule 41(a)(1)(A)(i) before HealthMarkets formally responded. No specific reason was stated on the record; strategic licensing resolution is a common driver of such outcomes in multi-defendant NPE campaigns.
The active assertion of these five patents in a coordinated multi-defendant campaign signals ongoing enforcement risk for companies operating intelligent routing and digital matching platforms. Related cases should be monitored for substantive claim construction rulings.
Ready to Strengthen Your Patent Strategy?
Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.
References & Further Resources
- PACER — Case No. 2:24-cv-00028, E.D. Tex.
- USPTO Patent Center — Patent Prosecution Histories
- Cornell Legal Information Institute — Federal Rule of Civil Procedure 41
- PatSnap — IP Intelligence Solutions for Law Firms
This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.